Procter & Gamble Health Limited has informed the Exchange about General Updates
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Limited has received shareholder approval for the appointment of Mr. Sharad Tyagi (DIN: 00371842) and Ms. Krishna Sarma (DIN: 00016115) as Non-Executive Independent Directors for a five-year term. The two were initially appointed as Additional Directors effective April 1, 2025, subject to shareholder approval. The approval was secured via a postal ballot, with shareholders voting in favor on April 9, 2025, and results declared on April 10, 2025. This formalises their board positions and completes the regulatory appointment process.
This is a routine governance update with no material impact on financials or operations. It simply confirms the board composition, which may slightly strengthen independent oversight on the board.